Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1857
mi
from 98109
Avon, IN
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1857
mi
from 98109
Avon, IN
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1906
mi
from 98109
Franklin, IN
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1906
mi
from 98109
Franklin, IN
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2096
mi
from 98109
Slidell, LA
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2096
mi
from 98109
Slidell, LA
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2325
mi
from 98109
Baltimore, MD
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2325
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1367
mi
from 98109
Omaha, NE
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1367
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2392
mi
from 98109
Lebanon, NH
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2454
mi
from 98109
Nashua, NH
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2454
mi
from 98109
Nashua, NH
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2395
mi
from 98109
Teaneck, NJ
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2395
mi
from 98109
Teaneck, NJ
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2351
mi
from 98109
Albany, NY
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2351
mi
from 98109
Albany, NY
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2426
mi
from 98109
Northport, NY
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2426
mi
from 98109
Northport, NY
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2310
mi
from 98109
Asheboro, NC
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2310
mi
from 98109
Asheboro, NC
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2416
mi
from 98109
Whiteville, NC
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2416
mi
from 98109
Whiteville, NC
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2455
mi
from 98109
Wilmington, NC
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2455
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1956
mi
from 98109
Dayton, OH
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1956
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1994
mi
from 98109
Delaware, OH
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1994
mi
from 98109
Delaware, OH
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1538
mi
from 98109
Norman, OK
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1538
mi
from 98109
Norman, OK
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2432
mi
from 98109
Murrells Inlet, SC
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2432
mi
from 98109
Murrells Inlet, SC
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2150
mi
from 98109
Kingsport, TN
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2150
mi
from 98109
Kingsport, TN
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1358
mi
from 98109
Amarillo, TX
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1358
mi
from 98109
Amarillo, TX
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1677
mi
from 98109
Dallas, TX
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1677
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1892
mi
from 98109
Houston, TX
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1515
mi
from 98109
Midland, TX
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1515
mi
from 98109
Midland, TX
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1787
mi
from 98109
San Antonio, TX
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2259
mi
from 98109
Winchester, VA
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2259
mi
from 98109
Winchester, VA
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
48
mi
from 98109
Olympia, WA
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
48
mi
from 98109
Olympia, WA
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from 98109
Aalborg,
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from 98109
Aalborg,
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1754
mi
from 98109
Buckley, MI
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1754
mi
from 98109
Buckley, MI
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1961
mi
from 98109
Franklin, OH
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1961
mi
from 98109
Franklin, OH
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2350
mi
from 98109
Richmond, VA
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2350
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2115
mi
from 98109
West Seneca, NY
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2115
mi
from 98109
West Seneca, NY
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1194
mi
from 98109
Fargo, ND
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1194
mi
from 98109
Fargo, ND
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1706
mi
from 98109
Gurnee, IL
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1706
mi
from 98109
Gurnee, IL
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
993
mi
from 98109
Costa Mesa, CA
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
993
mi
from 98109
Costa Mesa, CA
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2714
mi
from 98109
Cooper City, FL
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2714
mi
from 98109
Cooper City, FL
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2434
mi
from 98109
Myrtle Beach, SC
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2434
mi
from 98109
Myrtle Beach, SC
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2512
mi
from 98109
Clearwater, FL
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2512
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2416
mi
from 98109
New Hyde Park, NY
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2416
mi
from 98109
New Hyde Park, NY
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1056
mi
from 98109
La Jolla, CA
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1056
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2720
mi
from 98109
Miami Lakes, FL
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2720
mi
from 98109
Miami Lakes, FL
Click here to add this to my saved trials
Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors
Characteristics and Cardiovascular and Mortality Outcomes in Patients With Type 2 Diabetes Mellitus Initiating Treatment With Sodium-glucose Co-transporter-2 Inhibitors (SGLT-2i) and Other Glucose Lowering Drugs
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2361
mi
from 98109
Wilmington, DE
Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors
Characteristics and Cardiovascular and Mortality Outcomes in Patients With Type 2 Diabetes Mellitus Initiating Treatment With Sodium-glucose Co-transporter-2 Inhibitors (SGLT-2i) and Other Glucose Lowering Drugs
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2361
mi
from 98109
Wilmington, DE
Click here to add this to my saved trials
Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors
Characteristics and Cardiovascular and Mortality Outcomes in Patients With Type 2 Diabetes Mellitus Initiating Treatment With Sodium-glucose Co-transporter-2 Inhibitors (SGLT-2i) and Other Glucose Lowering Drugs
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from 98109
Melbourne,
Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors
Characteristics and Cardiovascular and Mortality Outcomes in Patients With Type 2 Diabetes Mellitus Initiating Treatment With Sodium-glucose Co-transporter-2 Inhibitors (SGLT-2i) and Other Glucose Lowering Drugs
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from 98109
Melbourne,
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
967
mi
from 98109
Huntington Park, CA
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
967
mi
from 98109
Huntington Park, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
699
mi
from 98109
San Carlos, CA
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
699
mi
from 98109
San Carlos, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2725
mi
from 98109
Hialeah, FL
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2725
mi
from 98109
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from 98109
Miami Lakes, FL
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from 98109
Miami Lakes, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2692
mi
from 98109
West Palm Beach, FL
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2692
mi
from 98109
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2440
mi
from 98109
Calabash, NC
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2440
mi
from 98109
Calabash, NC
Click here to add this to my saved trials